• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • LinkedIn
  • YouTube
  • Instagram
  • X
  • Contact Us
  • Clinical Trials
  • Careers
  • Investors
Insmed Insmed

Insmed

  • Company

    Company

    Get to know Insmed, see what drives us, and learn how weโ€™re building a company where people come first.

    Learn about our company

    • Culture
    • What Guides Us
    • Management Team
    • Board of Directors
    • Partnerships

    Our Global Company

    Find available career opportunities in the U.S., Japan, or Europe.

    Find Jobs

  • Patients

    Patients

    See how we collaborate with patients to shape every step of our shared journey.

    Learn about our
    commitment to patients

    • Disease Areas
    • Patient Advocacy & Resources
    • Patient Access

    Current Clinical Trials

    Learn more about our clinical trials or find a relevant trial near you.

    See if you may qualify

  • Science

    Science

    Discover the innovative science that fuels our commitment to delivering breakthroughs.

    Learn about our science

    • Pipeline
    • Areas of Innovation
      • Gene Therapy with Targeted Delivery
      • Protein Deimmunization
      • RNA End-Joining
      • Synthetic Rescue
    • Investigator-Initiated Research
    • Grants & Funding
  • Therapies

    Therapies

    Learn about our therapies

    • ARIKAYCEยฎ
    • BRINSUPRIยฎ
  • Responsibility

    Responsibility

    See how weโ€™re continuing to advance science sustainably and ethically.

    Learn about our
    commitment to responsibility

    • Patients we serve
    • Innovation we deliver
    • People we empower
    • Communities we strengthen
    • Planet we protect
    • Governance we uphold
      • Global Healthcare Compliance
      • Policies & Disclosures

    Responsibility Report

    Our Responsibility Report reflects the culture and purpose we live by every day. We are committed to reporting annually on our progress and commitments.

    Learn more

  • Company
    • Company
    • Culture
    • What Guides Us
    • Management Team
    • Board of Directors
    • Partnerships
  • Patients
    • Patients
    • Disease Areas
    • Patient Advocacy & Resources
    • Patient Access
  • Science
    • Science
    • Pipeline
    • Areas of Innovation
      • Gene Therapy with Targeted Delivery
      • Protein Deimmunization
      • RNA End-Joining
      • Synthetic Rescue
    • Investigator-Initiated Research
    • Grants & Funding
  • Therapies
    • Therapies
    • ARIKAYCEยฎ
      BRINSUPRIยฎ
  • Responsibility
    • Responsibility
    • Patients we serve
    • Innovation we deliver
    • People we empower
    • Communities we strengthen
    • Planet we protect
    • Governance we uphold
    • Global Healthcare Compliance
    • Policies & Disclosures
  • Investors
  • Press Releases
  • Events & Presentations
  • Financials & Filings
    • Earnings Results
    • Annual Reports
    • SEC Filings
  • Corporate Governance
  • Responsibility Reports
  • Resources
    • Stock Information
    • Investor FAQs
    • Analyst Coverage
    • Email Alerts

Press Releases

Month Year
Su Mo Tu We Th Fr Sa
Month Year
Su Mo Tu We Th Fr Sa
Email Alerts
Advanced Search
  
Asset Types
           
 Basic Search
  • Oct 28, 2003
    Insmed Incorporated to Webcast Third Quarter Earnings Conference Call; Wednesday, November 5, at 11:00 a.m. ET - 10:00 a.m. CT

    Read more

  • Oct 16, 2003
    Insmed to Present to Rodman and Renshaw Healthcare Conference; Presentation to be Webcast Live
    Insmed to Present to Rodman and Renshaw Healthcare Conference; Presentation to be Webcast Live

    Read more

  • Sep 23, 2003
    Insmed to Offer Data Showing Efficacy of Drug Candidate in Breast Cancer
    Insmed to Offer Data Showing Efficacy of Drug Candidate in Breast Cancer

    Read more

  • Sep 15, 2003
    Insmed's Phase III Drug Candidate to Be Featured in Two Podium Presentations at European Society for Paediatric Endocrinology
    Insmed's Phase III Drug Candidate to Be Featured in Two Podium Presentations at European Society for Paediatric Endocrinology

    Read more

  • Sep 5, 2003
    Company Profile for Insmed Incorporated
    Company Profile for Insmed Incorporated

    Read more

  • Jul 31, 2003
    Insmed Incorporated Reports Improved Financial Results for Second Quarter and First Half of 2003
    Insmed Incorporated Reports Improved Financial Results for Second Quarter and First Half of 2003

    Read more

  • Jul 24, 2003
    Insmed Incorporated to Webcast Second Quarter Earnings Conference Call; Thursday, July 31, at 11:00 a.m. ET - 10:00 a.m. CT
    Insmed Incorporated to Webcast Second Quarter Earnings Conference Call; Thursday, July 31, at 11:00 a.m. ET - 10:00 a.m. CT

    Read more

  • Jul 16, 2003
    Insmed Inc. Conludes Private Placement Led by Wells Fargo Securities Raising $1.9 Million More Than Previously Reported
    Insmed Inc. Conludes Private Placement Led by Wells Fargo Securities Raising $1.9 Million More Than Previously Reported

    Read more

  • Jul 14, 2003
    Insmed Reports Positive Data to AACR with rhIGFBP-3 in Cancer
    Insmed Reports Positive Data to AACR with rhIGFBP-3 in Cancer

    Read more

  • Jul 11, 2003
    Insmed Inc. Raises $12 Million in Private Placement of Common Stock Lead by Wells Fargo Securities
    Insmed Inc. Raises $12 Million in Private Placement of Common Stock Lead by Wells Fargo Securities

    Read more

Show 5102550100 per page
  • «
  • 1
  • …
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • …
  • 78
  • »
Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Sign Up

Investor Presentation

View the latest Insmed Investor Presentation

Download

Footer

Insmed

LinkedIn YouTube Instagram X

Terms of Use Privacy Policy California Notice at Collection U.S. Consumer Health Data Privacy Policy Your Privacy Choices

ยฉ 2026 Insmed Incorporated. All Rights Reserved.

You are now leaving Insmed's website.

Insmed does not control, review, or endorse third-party websites, and you agree that Insmed is not responsible for the content of the website you are about to enter.